CVS vs PETS
CVS Health Corp. and Petmed Express Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CVS | PETS |
|---|---|---|
| Revenue | $402.1B | $179.0M |
| Net income | $1.8B | $-57.3M |
| Gross margin | 45.0% | 28.1% |
| Net margin | 0.4% | −32.0% |
| Return on equity | 2.3% | −100.4% |
| Diluted EPS | $1.39 | −$2.74 |
| Dividend / share | $2.66 | $0.00 |
| Payout ratio | 192.1% | −0.0% |
| Free cash flow | $7.8B | $-33.0M |
| Equity | $75.2B | $28.9M |
| Net debt / equity | 0.69× | · |
| Current ratio | 0.84× | 0.84× |
| Revenue CAGR 5y | 8.4% | −10.0% |
| Profit CAGR 5y | −24.4% | · |
CVS bills 2245.9× the revenue of PETS, and PETS closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CVS | PETS |
|---|---|---|
| FY2025 | $402.1B | $179.0M |
| FY2024 | $372.8B | $227.0M |
| FY2023 | $357.8B | $274.1M |
| FY2022 | $322.5B | $247.6M |
| FY2021 | $292.1B | $272.3M |
| FY2020 | $268.7B | $303.6M |
| FY2019 | $256.8B | $284.1M |
| FY2018 | $194.6B | $283.4M |
| FY2017 | $184.8B | $273.8M |
| FY2016 | $177.5B | $249.2M |
Bottom line
| Fiscal year | CVS | PETS |
|---|---|---|
| FY2025 | $1.8B | $-57.3M |
| FY2024 | $4.6B | $-6.3M |
| FY2023 | $8.3B | $-7.5M |
| FY2022 | $4.3B | $5.1M |
| FY2021 | $8.0B | $18.7M |
| FY2020 | $7.2B | $23.9M |
| FY2019 | $6.6B | $25.9M |
| FY2018 | $-594.0M | $37.7M |
| FY2017 | $6.6B | $37.3M |
| FY2016 | $5.3B | $23.8M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$401,887,979,000 | CVS |
| FY2024 | +$372,582,028,000 | CVS |
| FY2023 | +$357,501,905,000 | CVS |
| FY2022 | +$322,219,431,000 | CVS |
| FY2021 | +$291,838,718,000 | CVS |
| FY2020 | +$268,402,417,000 | CVS |
| FY2019 | +$256,491,875,000 | CVS |
| FY2018 | +$194,295,581,000 | CVS |
| FY2017 | +$184,512,200,000 | CVS |
| FY2016 | +$177,296,824,000 | CVS |
| FY2015 | +$153,055,316,000 | CVS |
| FY2014 | +$139,137,605,000 | CVS |
| FY2013 | +$126,527,609,000 | CVS |
| FY2012 | +$122,892,171,000 | CVS |
| FY2011 | +$106,841,750,000 | CVS |
| FY2010 | +$95,546,358,000 | CVS |
| FY2009 | +$97,976,734,000 | CVS |
CVS has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +32.4 pp | CVS |
| FY2024 | +4.0 pp | CVS |
| FY2023 | +5.1 pp | CVS |
| FY2022 | −0.7 pp | PETS |
| FY2021 | −4.1 pp | PETS |
| FY2020 | −5.2 pp | PETS |
| FY2019 | −6.5 pp | PETS |
| FY2018 | −13.6 pp | PETS |
| FY2017 | −10.0 pp | PETS |
| FY2016 | −6.6 pp | PETS |
| FY2015 | −5.3 pp | PETS |
| FY2014 | −4.3 pp | PETS |
| FY2013 | −4.1 pp | PETS |
| FY2012 | −4.4 pp | PETS |
| FY2011 | −3.8 pp | PETS |
| FY2010 | −5.4 pp | PETS |
| FY2009 | −7.1 pp | PETS |
The higher net margin has changed hands between CVS and PETS over this period.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PETS's net margin has been more volatile than CVS's over the 17 comparable fiscal years — 10.2 percentage points of standard deviation against 1.2.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CVS and PETS over these 17 fiscal years — CVS led in 3 and PETS in 14.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
PETS's return on equity has been more volatile than CVS's over the 17 comparable fiscal years — 30.4 percentage points of standard deviation against 4.4.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CVS and PETS over these 17 fiscal years — CVS led in 4 and PETS in 13.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.